Juliet Philips
Dana-Farber Cancer Institute(US)
Publications by Year
Research Areas
Pancreatic and Hepatic Oncology Research, Cancer Genomics and Diagnostics, Lung Cancer Treatments and Mutations, Neuroendocrine Tumor Research Advances, Blood Coagulation and Thrombosis Mechanisms
Most-Cited Works
- → Activation of ERBB2 Signaling Causes Resistance to the EGFR-Directed Therapeutic Antibody Cetuximab(2011)661 cited
- → Profiling Critical Cancer Gene Mutations in Clinical Tumor Samples(2009)432 cited
- → Somatic mutation of CDKN1B in small intestine neuroendocrine tumors(2013)368 cited
- → Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer(2009)318 cited
- → Relationship of CDX2 Loss with Molecular Features and Prognosis in Colorectal Cancer(2009)189 cited
- → High‐resolution analysis of genetic alterations in small bowel carcinoid tumors reveals areas of recurrent amplification and loss(2008)121 cited
- → Increased prevalence of the BRCA2 polymorphic stop codon K3326X among individuals with familial pancreatic cancer(2005)81 cited
- → TCF4 and CDX2, major transcription factors for intestinal function, converge on the same cis -regulatory regions(2010)79 cited
- → Fatty acid turnover rates in the adipose tissues of the growing chicken (Gallus domesticus)(1994)25 cited
- → Evaluation of Temperature Gradient Capillary Electrophoresis for Detection of the Factor V Leiden Mutation(2003)22 cited